Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises OsteoCentric on the public offer for Integrum
Mandate

Vinge advises OsteoCentric on the public offer for Integrum

July 23, 2025

OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.

Vinge’s team consists of Erik Sjöman, Sofie Bjärtun, Linnéa Dolk and Michaela Ådén (Capital Markets and Public M&A) and Daniel Wendelsson, Fredrik Hellström and Lovisa Arpi (FDI).

Related

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025

Vinge advises Hallbyggarna Jonsereds in conjunction with the acquisition of Renthall

 Hallbyggarna Jonsereds AB, part of the NSS Group, has acquired Renthall i Sverige AB, which has a turnover of SEK 40 million.
October 02, 2025